Virtual Medicinal Product (VMP) - Quadrivalent influenza vaccine (live attenuated) nasal suspension 0.2ml unit dose

Navigation

Name Details

Name Start Date End Date
Name Current Name Quadrivalent influenza vaccine (live attenuated) nasal suspension 0.2ml unit dose Start Date 29-08-2024 End Date
Previous Name Previous Name Influenza vaccine (live attenuated) nasal suspension 0.2ml unit dose Start Date 21-12-2011 End Date 28-08-2024
Abbreviated Name Abbreviated Name Quadrivalent influenza vacc (live attenuated) nsl susp 0.2ml Start Date 29-08-2024
Previous Abbreviated Name Influenza vacc (live attenuated) nsl susp 0.2ml unit dose Previous Start Date 21-12-2011 Previous End Date 28-08-2024

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
0.2
UDFS UOM
ml
Unit Dose UOM
unit dose

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Nasal
Form
Spray
Ontology Form/Route
suspensionspray.nasal
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
J07BB03
BNF Start Date End Date
Current BNF 14040000 Start Date 04-04-2022 End Date
Previous BNF 14040000 Start Date 04-12-2012 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
19821411000001103 15-12-2011

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Influenza virus live attenuated

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
2 ml
10 unit dose